Current Gastroenterology Reports

, Volume 13, Issue 3, pp 226–239

Ablative Therapies for Barrett’s Esophagus



Barrett’s esophagus has gained increased clinical attention because of its association with esophageal adenocarcinoma, a cancer with increasing incidence and poor survival rates. The goals of ablating Barrett’s esophagus are to decrease esophageal cancer rates and to improve overall survival and quality of life. Different techniques have been developed and tested for their effectiveness eradicating Barrett’s epithelium. This review assesses the literature associated with different ablative techniques. The safety and efficacy of different techniques are discussed. This review concludes with recommendations for the clinician, including specific strategies for patient care decisions for patients with Barrett’s esophagus with varying degrees of dysplasia.


Ablation Argon plasma coagulation Barrett’s esophagus Cryotherapy Dysplasia Endoscopy Endoscopic mucosal resection Esophageal adenocarcinoma Photodynamic therapy Proton pump inhibitor Radiofrequency ablation 


Papers of particular interest, published recently, have been highlighted as: • Of importance

  1. 1.
    Eloubeidi MA, Mason AC, Desmond RA, El-Serag HB. Temporal trends (1973–1997) in survival of patients with esophageal adenocarcinoma in the United States: a glimmer of hope? Am J Gastroenterol. 2003;98:1627–33.PubMedGoogle Scholar
  2. 2.
    Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin. 2005;55:74–108.PubMedCrossRefGoogle Scholar
  3. 3.
    Polednak AP. Trends in survival for both histologic types of esophageal cancer in US surveillance, epidemiology and end results areas. Int J Cancer. 2003;105:98–100.PubMedCrossRefGoogle Scholar
  4. 4.
    Brown LM, Devesa SS, Chow WH. Incidence of adenocarcinoma of the esophagus among white Americans by sex, stage, and age. J Natl Cancer Inst. 2008;100:1184–7.PubMedCrossRefGoogle Scholar
  5. 5.
    Rex DK, Cummings OW, Shaw M, et al. Screening for Barrett's esophagus in colonoscopy patients with and without heartburn. Gastroenterology. 2003;125:1670–7.PubMedCrossRefGoogle Scholar
  6. 6.
    Hayeck TJ, Kong CY, Spechler SJ, et al. The prevalence of Barrett's esophagus in the US: estimates from a simulation model confirmed by SEER data. Dis Esophagus. 2010;23:451–7.PubMedCrossRefGoogle Scholar
  7. 7.
    Shaheen NJ, Crosby MA, Bozymski EM, Sandler RS. Is there publication bias in the reporting of cancer risk in Barrett's esophagus? Gastroenterology. 2000;119:333–8.PubMedCrossRefGoogle Scholar
  8. 8.
    Sikkema M, de Jonge PJ, Steyerberg EW, Kuipers EJ. Risk of esophageal adenocarcinoma and mortality in patients with Barrett's esophagus: a systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2010;8:235–44. quiz e32.PubMedCrossRefGoogle Scholar
  9. 9.
    • Shaheen NJ, Sharma P, Overholt BF, et al.: Radiofrequency ablation in Barrett's esophagus with dysplasia. N Engl J Med 2009;360:2277–88. This randomized clinical trial evaluated radiofrequency ablation in patients with dysplastic BE. PubMedCrossRefGoogle Scholar
  10. 10.
    Overholt BF, Lightdale CJ, Wang KK, et al. Photodynamic therapy with porfimer sodium for ablation of high-grade dysplasia in Barrett's esophagus: international, partially blinded, randomized phase III trial. Gastrointest Endosc. 2005;62:488–98.PubMedCrossRefGoogle Scholar
  11. 11.
    Konda VJ, Ross AS, Ferguson MK, et al. Is the risk of concomitant invasive esophageal cancer in high-grade dysplasia in Barrett's esophagus overestimated? Clin Gastroenterol Hepatol. 2008;6:159–64.PubMedCrossRefGoogle Scholar
  12. 12.
    Crockett SD, Lippmann QK, Dellon ES, Shaheen NJ. Health-related quality of life in patients with Barrett's esophagus: a systematic review. Clin Gastroenterol Hepatol. 2009;7:613–23.PubMedCrossRefGoogle Scholar
  13. 13.
    • Shaheen NJ, Peery AF, Hawes RH, et al.: Quality of life following radiofrequency ablation of dysplastic Barrett's esophagus. Endoscopy 2010;42:790–9. This article is one of the few reports of quality of life in patients with BE who undergo ablation. PubMedCrossRefGoogle Scholar
  14. 14.
    Prasad GA, Wang KK, Buttar NS, et al. Long-term survival following endoscopic and surgical treatment of high-grade dysplasia in Barrett's esophagus. Gastroenterology. 2007;132:1226–33.PubMedCrossRefGoogle Scholar
  15. 15.
    Inadomi JM, Somsouk M, Madanick RD, et al. A cost-utility analysis of ablative therapy for Barrett's esophagus. Gastroenterology. 2009;136:2101–14. e1-6.PubMedCrossRefGoogle Scholar
  16. 16.
    Curvers WL, ten Kate FJ, Krishnadath KK, et al. Low-grade dysplasia in Barrett's esophagus: overdiagnosed and underestimated. Am J Gastroenterol. 2010;105:1523–30.PubMedCrossRefGoogle Scholar
  17. 17.
    Montgomery E, Bronner MP, Goldblum JR, et al. Reproducibility of the diagnosis of dysplasia in Barrett esophagus: a reaffirmation. Hum Pathol. 2001;32:368–78.PubMedCrossRefGoogle Scholar
  18. 18.
    Ajumobi A, Bahjri K, Jackson C, Griffin R. Surveillance in Barrett's esophagus: an audit of practice. Dig Dis Sci. 2010;55:1615–21.PubMedCrossRefGoogle Scholar
  19. 19.
    Wang KK, Sampliner RE. Updated guidelines 2008 for the diagnosis, surveillance and therapy of Barrett's esophagus. Am J Gastroenterol. 2008;103:788–97.PubMedCrossRefGoogle Scholar
  20. 20.
    Lichtenstein DR, Cash BD, Davila R, et al. Role of endoscopy in the management of GERD. Gastrointest Endosc. 2007;66:219–24.PubMedCrossRefGoogle Scholar
  21. 21.
    Fleischer DE, Odze R, Overholt BF, et al. The case for endoscopic treatment of non-dysplastic and low-grade dysplastic Barrett's esophagus. Dig Dis Sci. 2010;55:1918–31.PubMedCrossRefGoogle Scholar
  22. 22.
    Falk GW. Radiofrequency ablation of Barrett's esophagus: let's not get ahead of ourselves. Dig Dis Sci. 2010;55:1811–4.PubMedCrossRefGoogle Scholar
  23. 23.
    Rees JR, Lao-Sirieix P, Wong A, Fitzgerald RC: Treatment for Barrett's oesophagus. Cochrane Database Syst Rev 2010:CD004060.Google Scholar
  24. 24.
    Sampliner RE, Fennerty B, Garewal HS. Reversal of Barrett's esophagus with acid suppression and multipolar electrocoagulation: preliminary results. Gastrointest Endosc. 1996;44:532–5.PubMedCrossRefGoogle Scholar
  25. 25.
    Sampliner RE, Faigel D, Fennerty MB, et al. Effective and safe endoscopic reversal of nondysplastic Barrett's esophagus with thermal electrocoagulation combined with high-dose acid inhibition: a multicenter study. Gastrointest Endosc. 2001;53:554–8.PubMedCrossRefGoogle Scholar
  26. 26.
    Sharma P, Bhattacharyya A, Garewal HS, Sampliner RE. Durability of new squamous epithelium after endoscopic reversal of Barrett's esophagus. Gastrointest Endosc. 1999;50:159–64.PubMedCrossRefGoogle Scholar
  27. 27.
    Dulai GS, Jensen DM, Cortina G, et al. Randomized trial of argon plasma coagulation vs. multipolar electrocoagulation for ablation of Barrett's esophagus. Gastrointest Endosc. 2005;61:232–40.PubMedCrossRefGoogle Scholar
  28. 28.
    Sharma P, Wani S, Weston AP, et al. A randomised controlled trial of ablation of Barrett's oesophagus with multipolar electrocoagulation versus argon plasma coagulation in combination with acid suppression: long term results. Gut. 2006;55:1233–9.PubMedCrossRefGoogle Scholar
  29. 29.
    Bright T, Watson DI, Tam W, et al. Randomized trial of argon plasma coagulation versus endoscopic surveillance for barrett esophagus after antireflux surgery: late results. Ann Surg. 2007;246:1016–20.PubMedCrossRefGoogle Scholar
  30. 30.
    Dulai GS, Guha S, Kahn KL, et al. Preoperative prevalence of Barrett's esophagus in esophageal adenocarcinoma: a systematic review. Gastroenterology. 2002;122:26–33.PubMedCrossRefGoogle Scholar
  31. 31.
    Chennat J, Konda VJ, Ross AS, et al. Complete Barrett's eradication endoscopic mucosal resection: an effective treatment modality for high-grade dysplasia and intramucosal carcinoma–an American single-center experience. Am J Gastroenterol. 2009;104:2684–92.PubMedCrossRefGoogle Scholar
  32. 32.
    Ackroyd R, Brown NJ, Davis MF, et al. Photodynamic therapy for dysplastic Barrett's oesophagus: a prospective, double blind, randomised, placebo controlled trial. Gut. 2000;47:612–7.PubMedCrossRefGoogle Scholar
  33. 33.
    Overholt BF, Wang KK, Burdick JS, et al. Five-year efficacy and safety of photodynamic therapy with Photofrin in Barrett's high-grade dysplasia. Gastrointest Endosc. 2007;66:460–8.PubMedCrossRefGoogle Scholar
  34. 34.
    Badreddine RJ, Prasad GA, Wang KK, et al. Prevalence and predictors of recurrent neoplasia after ablation of Barrett's esophagus. Gastrointest Endosc. 2010;71:697–703.PubMedCrossRefGoogle Scholar
  35. 35.
    Hage M, Siersema PD, van Dekken H, et al. 5-aminolevulinic acid photodynamic therapy versus argon plasma coagulation for ablation of Barrett's oesophagus: a randomised trial. Gut. 2004;53:785–90.PubMedCrossRefGoogle Scholar
  36. 36.
    Kelty CJ, Ackroyd R, Brown NJ, et al. Endoscopic ablation of Barrett's oesophagus: a randomized-controlled trial of photodynamic therapy vs. argon plasma coagulation. Aliment Pharmacol Ther. 2004;20:1289–96.PubMedCrossRefGoogle Scholar
  37. 37.
    Sharma VK, Wang KK, Overholt BF, et al. Balloon-based, circumferential, endoscopic radiofrequency ablation of Barrett's esophagus: 1-year follow-up of 100 patients. Gastrointest Endosc. 2007;65:185–95.PubMedCrossRefGoogle Scholar
  38. 38.
    Fleischer DE, Overholt BF, Sharma VK, et al. Endoscopic ablation of Barrett's esophagus: a multicenter study with 2.5-year follow-up. Gastrointest Endosc. 2008;68:867–76.PubMedCrossRefGoogle Scholar
  39. 39.
    • Fleischer DE, Overholt BF, Sharma VK, et al.: Endoscopic radiofrequency ablation for Barrett's esophagus: 5-year outcomes from a prospective multicenter trial. Endoscopy 2010;42:781–9. This study presents some of the longest follow-up data regarding ablation of nondysplastic BE as presented in the AIM-II study. PubMedCrossRefGoogle Scholar
  40. 40.
    Roorda AK, Marcus SN, Triadafilopoulos G. Early experience with radiofrequency energy ablation therapy for Barrett's esophagus with and without dysplasia. Dis Esophagus. 2007;20:516–22.PubMedCrossRefGoogle Scholar
  41. 41.
    Gondrie JJ, Pouw RE, Sondermeijer CM, et al. Stepwise circumferential and focal ablation of Barrett's esophagus with high-grade dysplasia: results of the first prospective series of 11 patients. Endoscopy. 2008;40:359–69.PubMedCrossRefGoogle Scholar
  42. 42.
    Gondrie JJ, Pouw RE, Sondermeijer CM, et al. Effective treatment of early Barrett's neoplasia with stepwise circumferential and focal ablation using the HALO system. Endoscopy. 2008;40:370–9.PubMedCrossRefGoogle Scholar
  43. 43.
    Sharma VK, Kim HJ, Das A, et al. A prospective pilot trial of ablation of Barrett's esophagus with low-grade dysplasia using stepwise circumferential and focal ablation (HALO system). Endoscopy. 2008;40:380–7.PubMedCrossRefGoogle Scholar
  44. 44.
    Hernandez JC, Reicher S, Chung D, et al. Pilot series of radiofrequency ablation of Barrett's esophagus with or without neoplasia. Endoscopy. 2008;40:388–92.PubMedCrossRefGoogle Scholar
  45. 45.
    Sharma VK. Jae Kim H, Das A, et al.: Circumferential and focal ablation of Barrett's esophagus containing dysplasia. Am J Gastroenterol. 2009;104:310–7.PubMedCrossRefGoogle Scholar
  46. 46.
    Ganz RA, Overholt BF, Sharma VK, et al. Circumferential ablation of Barrett's esophagus that contains high-grade dysplasia: a U.S. Multicenter Registry. Gastrointest Endosc. 2008;68:35–40.PubMedCrossRefGoogle Scholar
  47. 47.
    Pouw RE, Wirths K, Eisendrath P, et al. Efficacy of radiofrequency ablation combined with endoscopic resection for barrett's esophagus with early neoplasia. Clin Gastroenterol Hepatol. 2010;8:23–9.PubMedCrossRefGoogle Scholar
  48. 48.
    Velanovich V. Endoscopic endoluminal radiofrequency ablation of Barrett's esophagus: initial results and lessons learned. Surg Endosc. 2009;23:2175–80.PubMedCrossRefGoogle Scholar
  49. 49.
    Vassiliou MC, von Renteln D, Wiener DC, et al. Treatment of ultralong-segment Barrett's using focal and balloon-based radiofrequency ablation. Surg Endosc. 2010;24:786–91.PubMedCrossRefGoogle Scholar
  50. 50.
    Johnston MH, Eastone JA, Horwhat JD, et al. Cryoablation of Barrett's esophagus: a pilot study. Gastrointest Endosc. 2005;62:842–8.PubMedCrossRefGoogle Scholar
  51. 51.
    Dumot JA, Vargo 2nd JJ, Falk GW, et al. An open-label, prospective trial of cryospray ablation for Barrett's esophagus high-grade dysplasia and early esophageal cancer in high-risk patients. Gastrointest Endosc. 2009;70:635–44.PubMedCrossRefGoogle Scholar
  52. 52.
    Larghi A, Lightdale CJ, Memeo L, et al. EUS followed by EMR for staging of high-grade dysplasia and early cancer in Barrett's esophagus. Gastrointest Endosc. 2005;62:16–23.PubMedCrossRefGoogle Scholar
  53. 53.
    Chennat J, Konda VJ, Hart J, et al.: Complete Barrett's eradication endoscopic mucosal resection (CBE-EMR): long-term results of management of high grade dysplasia (HGD) and intramucosal carcinoma (IMC). In: Digestive Disease Week; 2010 May 2010; 2010. p. S1517.Google Scholar
  54. 54.
    • Pouw RE, Seewald S, Gondrie JJ, et al.: Stepwise radical endoscopic resection for eradication of Barrett's oesophagus with early neoplasia in a cohort of 169 patients. Gut 2010;59:1169–77. This is one of the largest studies of endoscopic mucosal resection as a strategy for ablation of BE. PubMedCrossRefGoogle Scholar
  55. 55.
    Van Vilsteren FG, Pouw RE, Seewald S, et al. A multi-center randomized trial comparing stepwise radical endoscopic resection versus radiofrequency ablation for Barrett esophagus containing high-grade dysplasia and/or early cancer, Abstract 939. Gastrointest Endosc. 2009;69:AB133–4.CrossRefGoogle Scholar
  56. 56.
    Eldaif SM, Lin E, Singh KA, et al. Radiofrequency ablation of Barrett's esophagus: short-term results. Ann Thorac Surg. 2009;87:405–10. discussion 10–1.PubMedCrossRefGoogle Scholar
  57. 57.
    • Shaheen NJ, Greenwald BD, Peery AF, et al.: Safety and efficacy of endoscopic spray cryotherapy for Barrett's esophagus with high-grade dysplasia. Gastrointest Endosc 2010;71:680–5. This study represents one of the largest reports of cryotherapy for ablation of BE. PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2011

Authors and Affiliations

  1. 1.Division of Gastroenterology, Institute for Genome Science and PolicyDuke UniversityDurhamUSA
  2. 2.Durham VA Medical CenterDurhamUSA
  3. 3.Center for Esophageal Diseases and SwallowingUniversity of North Carolina School of MedicineChapel HillUSA

Personalised recommendations